lactic acid has been researched along with succimer in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forth, W; Kreppel, H; Reichl, FX | 1 |
| Gopalratnam, PC; Mason, NS; Sparks, RE | 1 |
| Ben-Yoseph, O; Boxer, PA; Ross, BD | 1 |
| Hinds, CJ; Thiemermann, C; Wray, GM | 1 |
| Flohé, S; Kehe, K; Krebs, G; Kreppel, H; Liebl, B; Reichl, FX; Szinicz, L | 1 |
| Bandopadhyaya, GP; Shukla, J; Varma, IK | 1 |
| Amaral, AC; Bentes, R; Bocca, AL; Felipe, MS; Lacava, ZG; Morais, PC; Nunes, J; Peixoto, DL; Primo, FL; Ribeiro, AM; Simioni, AR; Tedesco, AC; Titze-de-Almeida, R | 1 |
| Azevedo, RB; Bocca, AL; Cunha-Azevedo, EP; Felipe, MS; Martins, OP; Silva, JR; Siqueira-Moura, MP; Tedesco, AC | 1 |
| Chowdhury, ST; Das, N; Dungdung, SR; Ghosh, D; Ghosh, S; Mandal, AK; Sarkar, S | 1 |
| Báo, SN; Cintra e Silva, Dde O; de Carvalho, RF; de Souza Filho, J; Lacava, ZG; Martins, OP; Miranda-Vilela, AL; Ribeiro, IF; Sampaio, RN; Tedesco, AC | 1 |
| Amaral, AC; Báo, SN; Bocca, AL; Borin, MF; Cardoso, VN; Cintra, DO; de Vasconcelos, NM; Felipe, MS; Fernandes, SO; Fuscaldi, LL; Jerônimo, MS; Martins, OP; Mortari, MR; Nascimento, AL; Pires Júnior, OR; R-Santos, L; Siqueira, IM; Souza, AC; Tedesco, AC; Titze-de-Almeida, R | 1 |
11 other study(ies) available for lactic acid and succimer
| Article | Year |
|---|---|
Pyruvate and lactate metabolism in livers of guinea pigs perfused with chelating agents after repeated treatment with As2O3.
Topics: Animals; Antidotes; Arsenic; Arsenic Trioxide; Arsenicals; Chelating Agents; Dimercaprol; Guinea Pigs; In Vitro Techniques; Lactates; Lactic Acid; Liver; Male; Oxides; Oxygen Consumption; Perfusion; Pyruvates; Pyruvic Acid; Succimer | 1991 |
Microencapsulation of astiban acid for the treatment of Schistosomiasis mansoni.
Topics: Antimony; Capsules; Humans; Lactates; Lactic Acid; Organometallic Compounds; Polyesters; Polymers; Schistosoma mansoni; Schistosomiasis; Schistosomicides; Succimer; Sulfhydryl Compounds | 1984 |
Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress.
Topics: Amitrole; Animals; Buthionine Sulfoximine; Carcinogens; Catalase; Cell Death; Cells, Cultured; Cerebral Cortex; Chelating Agents; Deferoxamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Glutamate-Cysteine Ligase; Glutathione; Hydrogen Peroxide; Iron; Lactates; Lactic Acid; Methionine Sulfoximine; Neuroglia; Neurons; Neuroprotective Agents; Oxidative Stress; Pentose Phosphate Pathway; Rats; Siderophores; Succimer | 1996 |
Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin.
Topics: Animals; Benzamides; Endotoxemia; Enzyme Inhibitors; Hemodynamics; Hypotension; Isoquinolines; Kidney; Lactic Acid; Liver; Male; Multiple Organ Failure; Niacinamide; Nitrates; Nitrites; Pancreas; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Succimer | 1998 |
Effects of Lewisite on cell membrane integrity and energy metabolism in human keratinocytes and SCL II cells.
Topics: Adenosine Triphosphate; Arsenicals; Cell Membrane Permeability; Cell Survival; Chelating Agents; Energy Metabolism; Formazans; Glucose; Humans; Keratinocytes; L-Lactate Dehydrogenase; Lactic Acid; Succimer; Tetrazolium Salts; Time Factors; Tumor Cells, Cultured; Unithiol | 2001 |
188Rhenium(V)-dimercaptosuccinic acid loaded poly(lactic-co-glycolic)acid microspheres for targeted radiotherapy: production and effectivity.
Topics: Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Excipients; Lactic Acid; Microscopy, Electron; Microspheres; Organometallic Compounds; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Rhenium; Spectrophotometry, Infrared; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid | 2005 |
Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis.
Topics: Amphotericin B; Animals; Body Weight; Bone Marrow; Colony Count, Microbial; Deoxycholic Acid; Drug Combinations; Female; Kidney; Lactic Acid; Liver; Lung; Mice; Mice, Inbred BALB C; Nanoparticles; Paracoccidioides; Paracoccidioidomycosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Succimer; Treatment Outcome | 2009 |
In vitro antifungal activity and toxicity of itraconazole in DMSA-PLGA nanoparticles.
Topics: Animals; Antifungal Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Itraconazole; Lactic Acid; Mice; Nanocapsules; Paracoccidioides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Succimer | 2011 |
Encapsulation of the flavonoid quercetin with an arsenic chelator into nanocapsules enables the simultaneous delivery of hydrophobic and hydrophilic drugs with a synergistic effect against chronic arsenic accumulation and oxidative stress.
Topics: Animals; Antioxidants; Arsenic; Arsenic Poisoning; Brain; Chelating Agents; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Drug Synergism; Female; Humans; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Liver; Nanoparticles; Oxidative Stress; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quercetin; Rats; Rats, Wistar; Succimer | 2011 |
Leishmanicidal activity of amphotericin B encapsulated in PLGA-DMSA nanoparticles to treat cutaneous leishmaniasis in C57BL/6 mice.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Biological Availability; Drug Delivery Systems; Drug Stability; Female; Lactic Acid; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Succimer | 2013 |
Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles.
Topics: Amphotericin B; Animals; Antifungal Agents; Deoxycholic Acid; Drug Carriers; Drug Combinations; Drug Liberation; Lactic Acid; Materials Testing; Mice; Nanoparticles; Paracoccidioides; Paracoccidioidomycosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Safety; Succimer; Tissue Distribution | 2015 |